| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/15/2010 | US20100093823 Steroidal compounds as melanogenesis modifiers and uses thereof |
| 04/15/2010 | US20100093790 Isoquinoline compounds |
| 04/15/2010 | US20100093760 Methods for identifying compounds that modulate cell signaling and methods employing such compounds |
| 04/15/2010 | US20100093737 Nucleoside and Nucleotide Analogues with Quaternary Carbon Centers and Methods of Use |
| 04/15/2010 | US20100093696 2-amino pyrimidine compounds |
| 04/15/2010 | US20100093649 Synthetic glycolipid analogues and derivatives for the treatment of pathologic disorders |
| 04/15/2010 | US20100093642 Novel polypeptides |
| 04/15/2010 | US20100093635 Agonists of Guanylate Cyclase UseFul For The Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| 04/15/2010 | US20100093633 Polypeptides having antimicrobial activity |
| 04/15/2010 | US20100093630 Mammalian chemokines; related reagents |
| 04/15/2010 | US20100093628 Methods of treatment using wisp polypeptides |
| 04/15/2010 | US20100093627 Albumin fusion proteins |
| 04/15/2010 | US20100093617 Use |
| 04/15/2010 | US20100093608 Modified animal erythropoietin polypeptides and their uses |
| 04/15/2010 | US20100093602 Methods and compositions for modulating adhesion and migration of cadherin expressing cells |
| 04/15/2010 | US20100093600 Regulation of neurotransmitters sequestration and release through manipulation of the vesicular functions |
| 04/15/2010 | US20100093556 Compositions and methods for treating and diagnosing cancer |
| 04/15/2010 | US20100093093 Manufacturing three-dimensional scaffolds using electrospinning at low temperatures |
| 04/15/2010 | US20100093092 Method for inducing pluripotency in cells |
| 04/15/2010 | US20100093091 Undifferentiated Stem Cell Culture Systems |
| 04/15/2010 | US20100093090 Method and kit for efficient reprogramming of somatic cells |
| 04/15/2010 | US20100093089 Dedifferentiation of adult mammalian cardiomyocytes into cardiac stem cells |
| 04/15/2010 | US20100093088 Retinoid compounds and their use |
| 04/15/2010 | US20100093087 IL-17 Mediated Transfection Methods |
| 04/15/2010 | US20100093086 Stapled Peptides and Method of Synthesis |
| 04/15/2010 | US20100093085 Tripartite oligonucleotide complexes and methods for gene silencing by rna interference |
| 04/15/2010 | US20100093084 Method for creating intracellular artificial nanostructures in situ |
| 04/15/2010 | US20100093083 Large scale production of stem cells |
| 04/15/2010 | US20100093082 Site Specific Incorporation of Non-Natural Amino Acids by Vertebrate Cells |
| 04/15/2010 | US20100093081 Methods and compositions for promoting survival & proliferation of endothelial cells & stimulating angiogenesis |
| 04/15/2010 | US20100093080 Tooth Regeneration Method |
| 04/15/2010 | US20100093079 Automated Tissue Staining System And Reagent Container |
| 04/15/2010 | US20100093078 Separating device, an algae culture photobioreactor, and methods of using them |
| 04/15/2010 | US20100093077 Extracellular matrix components for expansion or differentiation of hepatic progenitors |
| 04/15/2010 | US20100093057 Compositions and methods to prevent cancer by stabilizing p53 through non mdm2-mediated pathways |
| 04/15/2010 | US20100093053 Microcarriers for Stem Cell Culture |
| 04/15/2010 | US20100093039 Cell Culture Media for Enhanced Protein Production |
| 04/15/2010 | US20100093038 Means and Methods for Influencing the Stability of Cells |
| 04/15/2010 | US20100093035 Novel streptococcus antigens |
| 04/15/2010 | US20100093033 Inducible mutagenesis of target genes |
| 04/15/2010 | US20100093028 Modified variant bowman birk protease inhibitors |
| 04/15/2010 | US20100093027 3-phosphoinositide-dependent protein kinase that phosphorylates and activates protein kinase B alpha; drug target for cancer; drug screening for enzyme inhibitors as anticancer agents |
| 04/15/2010 | US20100093018 Cells expressing chimeric proteins and assays using such cells |
| 04/15/2010 | US20100093017 Metabolically Competent Cell Lines |
| 04/15/2010 | US20100093008 Phospho-specific antibodies to flt3 (tyr969) and uses thereof |
| 04/15/2010 | US20100093006 High affinity anti-n1,n12-diacetylspermine monoclonal antibody |
| 04/15/2010 | US20100093003 Methods to impair hematologic cancer progenitor cells and compounds related thereto |
| 04/15/2010 | US20100092998 Methods and compositions relating to e3 ring-e2 fusion proteins |
| 04/15/2010 | US20100092997 Method of Enhancing of Binding Activity of Antibody Composition to FcGamma Receptor IIIa |
| 04/15/2010 | US20100092994 High specificity monoclonal antibody against a protein or a polypeptide having oxidative modification |
| 04/15/2010 | US20100092978 Cadherin-17 as diagnostic marker and therapeutic target for liver cancer |
| 04/15/2010 | US20100092976 Thermostable duplex-specific nuclease |
| 04/15/2010 | US20100092975 Use of novel cytokine receptors as biomarkers and therapeutic targets in human cancer |
| 04/15/2010 | US20100092969 Cell isolation method, cell testing method and reagent kit therefor |
| 04/15/2010 | US20100092941 32142,21481,25964,21686, Novel dehydrogenase molecules and uses therefor |
| 04/15/2010 | US20100092938 Novel and Practical Serological Assay for the Clinical Diagnosis of Leishmaniasis |
| 04/15/2010 | US20100092640 UTILIZATION OF FATTY ACID DESATURASES FROM Hemiselmis spp. |
| 04/15/2010 | US20100092524 Modification of exosomal components for use as a vaccine |
| 04/15/2010 | US20100092522 Immunogenic wt-1 peptides and methods of use thereof |
| 04/15/2010 | US20100092520 Recombinant Plasmodium Falciparum Merozoite Surface Proteins 4 and 5 and Their Use |
| 04/15/2010 | US20100092515 Herpes simplex viruses and methods of viral replication |
| 04/15/2010 | US20100092503 Hcv fusion polypeptideds |
| 04/15/2010 | US20100092501 Foxp3 peptide vaccine |
| 04/15/2010 | US20100092498 Anti-Tumour Vaccine Derived from Normal Chemically Modified Cells |
| 04/15/2010 | US20100092494 Composition and method for facilitating the internalization of a therapeutic agent into a cell |
| 04/15/2010 | US20100092484 Cd44 antibodies |
| 04/15/2010 | US20100092481 Human cytomegalovirus neutralising antibodies and use thereof |
| 04/15/2010 | US20100092472 Compounds and methods for the modulation of beta-1 integrin function to mediate tissue repair |
| 04/15/2010 | US20100092460 Amino acid sequences directed against chemokines and polypeptides comprising the same for the treatment of chemokine-related diseases and disorders |
| 04/15/2010 | US20100092457 Diagnosis and Treatment of Cancer Using Anti-Desmoglein-3 Antibodies |
| 04/15/2010 | US20100092455 Novel anti-proliferation antibodies |
| 04/15/2010 | US20100092445 Adoptive immune cells for tumor vaccines |
| 04/15/2010 | US20100092436 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 04/15/2010 | US20100092435 Use of a varicellovirus tap-inhibitor for the induction of tumor-or virus-specific immunity against teipp |
| 04/15/2010 | US20100092434 Thrombopoietic activity of tyrosyl-trna synthetase polypeptides |
| 04/15/2010 | US20100092433 Vascularized islets and methods of producing same |
| 04/15/2010 | US20100092386 System for delivering therapeutic agents into living cells and cells nuclei |
| 04/15/2010 | CA2740092A1 Methods for isolating mesenchymal stem cells from embryo of human or animals and extracting secretion substances thereof |
| 04/15/2010 | CA2739902A1 Engineered cells expressing multiple immunomodulators and uses thereof |
| 04/15/2010 | CA2739771A1 Device for cell culture |
| 04/15/2010 | CA2739670A1 Oncostatin m as an enhancer of the immunostimulatory activity of human epithelial cells |
| 04/15/2010 | CA2739608A1 Recombinant nell protein production |
| 04/14/2010 | EP2175028A2 Phosphatase stress-related proteins and methods of use in plants |
| 04/14/2010 | EP2175017A1 Pseudomonas aeruginosa outer membrane protein pa4710 |
| 04/14/2010 | EP2175013A1 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 04/14/2010 | EP2174958A1 Antibodies derived from anti ed-b l19 and targeting tumor vasculature |
| 04/14/2010 | EP2174957A1 Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof |
| 04/14/2010 | EP2174955A1 Ifnar2 muteins, their production and use |
| 04/14/2010 | EP2174954A1 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 04/14/2010 | EP2174946A1 Methods for chemically synthesizing immunoglobulin chimeric proteins |
| 04/14/2010 | EP2173890A1 Biological active proteins having increased in vivo and/or vitro stability |
| 04/14/2010 | EP2173882A2 Secondary wall forming genes from maize and uses thereof |
| 04/14/2010 | EP2173864A1 Low rigidity gels for msc growth modulation |
| 04/14/2010 | EP2173863A1 Automated method and apparatus for embryonic stem cell culture |
| 04/14/2010 | EP2173862A1 Single pluripotent stem cell culture |
| 04/14/2010 | EP2173861A1 Methods of treating cell culture media for use in a bioreactor |
| 04/14/2010 | EP2173860A1 Culture medium for eukaryotic cells |
| 04/14/2010 | EP2173859A2 Soft gel systems in modulating stem cell development |
| 04/14/2010 | EP2173858A1 Biologically derived composite tissue engineering |
| 04/14/2010 | EP2173857A1 Cell culture substrate |